$80.71 -1.57 (%) Express Scripts Holding Co - NASDAQ

Jan. 30, 2015 | 04:00 PM

Partner Headlines

  1. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga | Jan. 29, 2015 | 14:18PM EST
  2. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum And Express Scripts

    Benzinga | Jan. 29, 2015 | 06:57AM EST
  3. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  4. Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

    GuruFocus | Jan. 22, 2015 | 12:32PM EST
  5. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD | Jan. 21, 2015 | 12:55PM EST
  6. Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year

    Benzinga | Jan. 20, 2015 | 16:21PM EST
  7. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD | Jan. 16, 2015 | 15:43PM EST
  8. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga | Jan. 15, 2015 | 11:14AM EST
  9. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus | Jan. 13, 2015 | 19:10PM EST
  10. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  11. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  12. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus | Jan. 13, 2015 | 14:55PM EST
  13. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  15. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  16. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus | Jan. 6, 2015 | 12:22PM EST
  17. Hepatitis Drugs Vie For Share

    IBD | Jan. 5, 2015 | 18:44PM EST
  18. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD | Jan. 5, 2015 | 18:21PM EST
  19. Stocks Lose More Ground; Gilead Sciences Rises

    IBD | Jan. 5, 2015 | 15:10PM EST
  20. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD | Jan. 5, 2015 | 15:09PM EST
  21. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD | Jan. 2, 2015 | 18:13PM EST
  22. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga | Jan. 2, 2015 | 09:36AM EST
  23. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  24. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD | Dec. 29, 2014 | 11:59AM EST
  25. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD | Dec. 27, 2014 | 08:02AM EST
  26. IBD 50: Biotechs Hammered, Then Find Support

    IBD | Dec. 26, 2014 | 18:27PM EST
  27. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases in Value by 35%

    GuruFocus | Dec. 26, 2014 | 17:44PM EST
  28. Biotech Stocks Take A Beating, But Find Support

    IBD | Dec. 24, 2014 | 16:56PM EST
  29. Stocks Score Small Gains; Virgin America Takes Flight

    IBD | Dec. 24, 2014 | 11:57AM EST
  30. How Gilead And Johnson & Johnson's Tumble Affected These Hedge Funds

    Benzinga | Dec. 24, 2014 | 11:27AM EST
  31. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis Pact

    Benzinga | Dec. 23, 2014 | 16:13PM EST
  32. Toys, Department Stores Rock, But Biotechs Tumble

    IBD | Dec. 23, 2014 | 12:06PM EST
  33. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price War'

    Benzinga | Dec. 23, 2014 | 10:56AM EST
  34. AbbVie Drug Displaces Gilead

    IBD | Dec. 22, 2014 | 18:38PM EST
  35. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD | Dec. 22, 2014 | 18:23PM EST
  36. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD | Dec. 22, 2014 | 17:59PM EST
  37. Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of AbbVie

    GuruFocus | Dec. 22, 2014 | 15:50PM EST
  38. Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing War

    Benzinga | Dec. 22, 2014 | 15:04PM EST
  39. Broad Indexes Little Changed; Facebook Breaks Out

    IBD | Dec. 22, 2014 | 13:11PM EST
  40. Dow Outperforms While Nasdaq Holds Small Gain; Oil Weak

    IBD | Dec. 22, 2014 | 11:58AM EST
  41. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD | Dec. 22, 2014 | 11:25AM EST
  42. Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment To Buy Caesars Acquisition

    Benzinga | Dec. 22, 2014 | 10:41AM EST
  43. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  44. Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

    Benzinga | Dec. 22, 2014 | 09:46AM EST
  45. Stock Futures Point Higher; AbbVie Surges, Gilead Dives

    IBD | Dec. 22, 2014 | 09:10AM EST
  46. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD | Dec. 19, 2014 | 19:05PM EST
  47. How Can Drugmakers Handle New Pricing Pressures?

    IBD | Dec. 11, 2014 | 17:38PM EST
  48. Are These Drugstore Retailers Good Investments?

    GuruFocus | Dec. 11, 2014 | 11:20AM EST
  49. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus | Dec. 10, 2014 | 11:26AM EST
  50. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus | Dec. 8, 2014 | 10:16AM EST
Trading Center